Related content

Recent advances in proteasome inhibitor discovery

By Pevzner Yuri   Metcalf Rainer   Kantor Melanie   Sagaro Desiree   Daniel Kenyon  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 5, 2013-06 ,pp. : 537-568

Informa Healthcare

Access to resources Recommend Favorite

A review of the proteasome inhibitor bortezomib in multiple myeloma

By Richardson Paul G  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1321-1331

Informa Healthcare

Access to resources Recommend Favorite

Clioquinol - A Novel Copper-Dependent and Independent Proteasome Inhibitor

By  

Current Cancer Drug Targets, Vol. 11, Iss. 3, 2011-03 ,pp. : 325-331

Bentham Science Publishers

Access to resources Recommend Favorite

An update on recent patents on thrombin inhibitors (2010 – 2013)

By Mehta Akul Y   Jin Yingzi   Desai Umesh R  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 47-67

Informa Healthcare

Access to resources Recommend Favorite

Selective JAK1 inhibitor and selective Tyk2 inhibitor patents

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 10, 2012-10 ,pp. : 1233-1249

Informa Healthcare

Access to resources Recommend Favorite